Annual Operating Expenses
$6.32 M
-$2.33 M-26.91%
September 30, 2024
Summary
- As of February 12, 2025, EDSA annual total operating expenses is $6.32 million, with the most recent change of -$2.33 million (-26.91%) on September 30, 2024.
- During the last 3 years, EDSA annual operating expenses has fallen by -$7.02 million (-52.65%).
- EDSA annual operating expenses is now -64.09% below its all-time high of $17.59 million, reached on September 30, 2022.
Performance
EDSA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$967.20 K
-$729.00 K-42.98%
September 30, 2024
Summary
- As of February 12, 2025, EDSA quarterly total operating expenses is $967.20 thousand, with the most recent change of -$729.00 thousand (-42.98%) on September 30, 2024.
- Over the past year, EDSA quarterly operating expenses has dropped by -$949.30 thousand (-49.53%).
- EDSA quarterly operating expenses is now -83.32% below its all-time high of $5.80 million, reached on June 30, 2022.
Performance
EDSA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
EDSA Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -26.9% | -49.5% |
3 y3 years | -52.6% | -53.1% |
5 y5 years | +101.0% | -53.1% |
EDSA Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -64.1% | at low | -83.3% | at low |
5 y | 5-year | -64.1% | +101.0% | -83.3% | at low |
alltime | all time | -64.1% | +7946.5% | -83.3% | +155.4% |
Edesa Biotech Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | $6.32 M(-26.9%) | $967.20 K(-43.0%) |
Jun 2024 | - | $1.70 M(-11.5%) |
Mar 2024 | - | $1.92 M(+10.4%) |
Dec 2023 | - | $1.74 M(-2.9%) |
Sep 2023 | $8.64 M(-50.9%) | $1.79 M(-13.4%) |
Jun 2023 | - | $2.06 M(-14.4%) |
Mar 2023 | - | $2.41 M(+1.4%) |
Dec 2022 | - | $2.38 M(-16.1%) |
Sep 2022 | $17.59 M(+31.9%) | $2.84 M(-51.1%) |
Jun 2022 | - | $5.80 M(+26.7%) |
Mar 2022 | - | $4.58 M(+4.4%) |
Dec 2021 | - | $4.38 M(+21.0%) |
Sep 2021 | $13.34 M(+98.8%) | $3.62 M(-24.0%) |
Jun 2021 | - | $4.77 M(+103.7%) |
Mar 2021 | - | $2.34 M(-10.5%) |
Dec 2020 | - | $2.61 M(+30.1%) |
Sep 2020 | $6.71 M(+113.6%) | $2.01 M(+7.0%) |
Jun 2020 | - | $1.88 M(+16.1%) |
Mar 2020 | - | $1.62 M(+33.6%) |
Dec 2019 | - | $1.21 M(-5.5%) |
Sep 2019 | $3.14 M(-35.2%) | $1.28 M(-3.1%) |
Jun 2019 | - | $1.32 M(-22.4%) |
Mar 2019 | - | $1.70 M(+25.7%) |
Dec 2018 | - | $1.35 M(+17.5%) |
Sep 2018 | $4.84 M(-1.5%) | $1.15 M(+3.1%) |
Jun 2018 | - | $1.12 M(-12.0%) |
Mar 2018 | - | $1.27 M(-3.2%) |
Dec 2017 | - | $1.31 M(+2.5%) |
Sep 2017 | $4.92 M(-2.6%) | $1.28 M(+9.0%) |
Jun 2017 | - | $1.17 M(+8.9%) |
Mar 2017 | - | $1.08 M(-22.8%) |
Dec 2016 | - | $1.39 M(+0.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2016 | $5.05 M(+18.7%) | $1.39 M(+16.7%) |
Jun 2016 | - | $1.19 M(+10.8%) |
Mar 2016 | - | $1.07 M(-23.2%) |
Dec 2015 | - | $1.40 M(+29.4%) |
Sep 2015 | $4.26 M(+803.1%) | $1.08 M(+44.5%) |
Jun 2015 | - | $747.90 K(-29.9%) |
Mar 2015 | - | $1.07 M(-21.6%) |
Dec 2014 | - | $1.36 M(+39.3%) |
Sep 2014 | $471.40 K(-91.2%) | - |
Aug 2014 | $5.33 M(+40.7%) | $977.30 K(-26.3%) |
May 2014 | - | $1.33 M(-7.8%) |
Feb 2014 | - | $1.44 M(-9.5%) |
Nov 2013 | - | $1.59 M(+16.5%) |
Aug 2013 | $3.79 M(-39.8%) | $1.36 M(+79.2%) |
May 2013 | - | $760.40 K(-6.0%) |
Feb 2013 | - | $809.10 K(-5.6%) |
Nov 2012 | - | $856.70 K(-50.6%) |
Aug 2012 | $6.30 M(+39.3%) | $1.73 M(+10.5%) |
May 2012 | - | $1.57 M(+17.5%) |
Feb 2012 | - | $1.33 M(-19.6%) |
Nov 2011 | - | $1.66 M(-195.2%) |
Aug 2011 | $4.52 M(+194.6%) | -$1.74 M(-241.6%) |
May 2011 | - | $1.23 M(-71.4%) |
Feb 2011 | - | $4.31 M(+503.6%) |
Nov 2010 | - | $713.60 K(-9.5%) |
Aug 2010 | $1.53 M(+1854.3%) | $788.50 K(+73.1%) |
May 2010 | - | $455.50 K(+3931.0%) |
Jan 2010 | - | $11.30 K(-69.2%) |
Oct 2009 | - | $36.70 K(+522.0%) |
Apr 2009 | $78.50 K | $5900.00(+7.3%) |
Jan 2009 | - | $5500.00(-91.7%) |
Oct 2008 | - | $66.30 K |
FAQ
- What is Edesa Biotech annual total operating expenses?
- What is the all time high annual operating expenses for Edesa Biotech?
- What is Edesa Biotech annual operating expenses year-on-year change?
- What is Edesa Biotech quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Edesa Biotech?
- What is Edesa Biotech quarterly operating expenses year-on-year change?
What is Edesa Biotech annual total operating expenses?
The current annual operating expenses of EDSA is $6.32 M
What is the all time high annual operating expenses for Edesa Biotech?
Edesa Biotech all-time high annual total operating expenses is $17.59 M
What is Edesa Biotech annual operating expenses year-on-year change?
Over the past year, EDSA annual total operating expenses has changed by -$2.33 M (-26.91%)
What is Edesa Biotech quarterly total operating expenses?
The current quarterly operating expenses of EDSA is $967.20 K
What is the all time high quarterly operating expenses for Edesa Biotech?
Edesa Biotech all-time high quarterly total operating expenses is $5.80 M
What is Edesa Biotech quarterly operating expenses year-on-year change?
Over the past year, EDSA quarterly total operating expenses has changed by -$949.30 K (-49.53%)